Terada T, Nakanuma Y
Second Department of Pathology, Kanazawa University School of Medicine, Japan.
Am J Clin Pathol. 1996 May;105(5):613-20. doi: 10.1093/ajcp/105.5.613.
Aberrant or incomplete glycosylation of mucins results in expression of T, Tn, and sialyl-Tn (STn) antigens in various malignant neoplasms. MUC-1 gene product (a mucin core protein of mammary type) is known to alter or overexpress in several malignant tumors. However, expression of these mucin-related antigens has rarely been examined in intraductal papillary-mucinous neoplasm (IPN) of the pancreas. The authors examined immunohistochemically the expression of these antigens and MUC-1 gene product in nine IPN. In normal pancreas (n = 5), pancreatic ducts did not express T, Tn, or STn antigens, but expressed MUC-1 gene product. Among the nine IPNs, two (22%) expressed T antigen, nine (100%) expressed Tn antigen, and seven (78%) expressed STn antigen. MUC-1 gene product was expressed in nine (100%) IPNs. In invasive ductal adenocarcinoma of the pancreas (n = 6), all cases showed strong expression of Tn and STn antigens and the MUC-1 gene product, but expressed no T antigen. The expression of these antigens and MUC-1 gene product was focal in IPN, whereas it was diffuse in invasive ductal adenocarcinoma of the pancreas. These data suggest that aberrant or incomplete glycosylation occurs in epithelial mucins of IPN, that IPN is a borderline or low grade malignant neoplasm in terms of mucin-related antigen expression, and that mucin core protein (MUC-1 gene product) does not alter during pancreatic ductal carcinogenesis.
粘蛋白的异常或不完全糖基化导致多种恶性肿瘤中T、Tn和唾液酸化Tn(STn)抗原的表达。已知MUC-1基因产物(乳腺型粘蛋白核心蛋白)在几种恶性肿瘤中会发生改变或过度表达。然而,这些粘蛋白相关抗原在胰腺导管内乳头状粘液性肿瘤(IPN)中的表达很少被研究。作者对9例IPN进行了免疫组织化学检测,以观察这些抗原和MUC-1基因产物的表达情况。在正常胰腺(n = 5)中,胰腺导管不表达T、Tn或STn抗原,但表达MUC-1基因产物。在9例IPN中,2例(22%)表达T抗原,9例(100%)表达Tn抗原,7例(78%)表达STn抗原。9例(100%)IPN均表达MUC-1基因产物。在胰腺浸润性导管腺癌(n = 6)中,所有病例均显示Tn和STn抗原以及MUC-1基因产物的强表达,但不表达T抗原。这些抗原和MUC-1基因产物在IPN中的表达是局灶性的,而在胰腺浸润性导管腺癌中是弥漫性的。这些数据表明,IPN的上皮粘蛋白中发生了异常或不完全糖基化,就粘蛋白相关抗原表达而言,IPN是一种临界或低级别恶性肿瘤,并且粘蛋白核心蛋白(MUC-1基因产物)在胰腺导管癌变过程中没有改变。